• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT I2000SR PROCESSING MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT I2000SR PROCESSING MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE Back to Search Results
Catalog Number 03M74-02
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/01/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.Section a1 patient identifier complete sid: (b)(6).
 
Event or Problem Description
The customer reported erratic architect ca 19-9xr results on a patient.It is unknown if the patient has pancreatic cancer.Results provided: ca 19-9 sid (b)(6): initial test 46.16 u/ml, second test 61.96 u/ml, third test 78.28 u/ml.Reference range 0-37 u/ml.No impact to patient management was reported.
 
Event or Problem Description
The customer reported erratic architect ca 19-9xr results on a patient.It is unknown if the patient has pancreatic cancer.Results provided: ca 19-9 sid (b)(6): initial test 46.16 u/ml, second test 61.96 u/ml, third test 78.28 u/ml.Reference range 0-37 u/ml.No impact to patient management was reported.
 
Additional Manufacturer Narrative
The architect i2000sr, serial # (b)(6) was evaluated, and it was determined that the sample probe required cleaning, which resolved the customer reported event.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The instrument service history review revealed no additional complaints associated with the customer reported event.A review of tracking and trending did not identify an increase in complaint activity for the architect i2000sr, serial # (b)(6) or arc, probe with regards to the customer reported event.A review of the manufacturing documentation did not identify any issues for the arc, probe as it relates to the customer reported event.Labeling was reviewed and was found to address the customer reported event.Based on the available information, no systemic issue or deficiency was identified for the architect i2000sr, serial # (b)(6) or arc, probe.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT I2000SR PROCESSING MODULE
Common Device Name
ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key23814998
Report Number3016438761-2025-00724
Device Sequence Number13082856
Product Code JJE
UDI-Device Identifier00380740006235
UDI-Public(01)00380740006235
Combination Product (Y/N)N
Initial Reporter CountryCH
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number03M74-02
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/01/2025
Supplement Date Received by Manufacturer01/09/2026
Initial Report FDA Received Date12/16/2025
Supplement Report FDA Received Date01/14/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/07/2019
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC CA19-9XR 100T (CN), 02K91-74, 74575FP00.; ARC CA19-9XR 100T (CN), 02K91-74, 74575FP00.
Patient SexUnknown
-
-